Ethylene-Vinyl Alcohol Copolymer Dialyzer Membrane Reduces Protein Oxidation in Hemodialysis Patients

REFERENCES

• Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl. 3):S112–S119.
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Heimbürger O, Paultre F, Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55(5):1899–1911.
   PubMed Web of Science ®Google Scholar
• Suliman ME, Qureshi AR, Bárány P, Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients. Kidney Int. 2000;57(4):1727–1735.
   PubMedGoogle Scholar
• Becker BN, Himmelfarb J, Henrich WL, Hakim RM. Reassessing the cardiac risk profile in chronic hemodialysis patients: A hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J Am Soc Nephrol. 1997;8(3):475–486.
   PubMed Web of Science ®Google Scholar
• Cheung AK, Sarnak MJ, Yan G, Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000;58(1):353–362.
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002;62(5): 1524–1538.
   PubMed Web of Science ®Google Scholar
• Doweiko JP, Nompleggi DJ. The role of albumin in human physiology and pathophysiology, Part III: Albumin and disease states. J Parenter Enteral Nutr. 1991;15(4):476–483.
   PubMed Web of Science ®Google Scholar
• Mera K, Anraku M, Kitamura K, Oxidation and carboxy methyl lysine-modification of albumin: Possible involvement in the progression of oxidative stress in hemodialysis patients. Hypertens Res. 2005;28(12):973–980.
   Google Scholar
• Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol. 1998;161(5):2524–2532.
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, McMonagle E, McMenamin E. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int. 2000;58(6):2571–2578.
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, McMenamin E, McMonagle E. Plasma aminothiol oxidation in chronic hemodialysis patients. Kidney Int. 2002;61(2):705–716.
   Google Scholar
• Roselaar SE, Nazhat NB, Winyard PG, Jones P, Cunningham J, Blake DR. Detection of oxidants in uremic plasma by electron spin resonance spectroscopy. Kidney Int. 1995;48(1): 199–206.
   PubMed Web of Science ®Google Scholar
• Tetta C, Biasioli S, Schiavon R, An overview of hemodialysis and oxidant stress. Blood Purif. 1999;17(2–3):118–126.
   Google Scholar
• Gawaz MP, Mujais SK, Schmidt B, Gurland HJ. Platelet-leukocyte aggregation during hemodialysis. Kidney Int. 1994;46(2):489–495.
   PubMed Web of Science ®Google Scholar
• Sirolli V, Ballone E, Di Stante S, Amoroso L, Bonomini M. Cell activation and cellular-cellular interactions during hemodialysis: Effect of dialyzer membrane. Int J Artif Organs. 2002;25(6):529–537.
   PubMed Web of Science ®Google Scholar
• Akiba T, Shibamoto T, Yamada T, Dialyzer clearance for dextran by high performance liquid chromatography. Jpn J Artif Organs. 1989;18(3):1232–1235.
   Google Scholar
• Soejima A, Kaneda F, Manno S, Useful markers for detecting decreased serum antioxidant activity in hemodialysis patients. Am J Kidney Dis. 2002;39(5):1040–1046.
   Google Scholar
• Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49(5):1304–1313.
   PubMed Web of Science ®Google Scholar
• Sogami M, Era S, Nagaoka S, HPLC-studies on nonmercapt-mercapt conversion of human serum albumin. Int J Pept Protein Res. 1985;25(4):398–402.
   Google Scholar
• Terawaki H, Yoshimura K, Hasegawa T, Oxidative stress is enhanced in correlation with renal dysfunction: Examination with the redox state of albumin. Kidney Int. 2004;66(5):1988–1993.
   PubMed Web of Science ®Google Scholar
• Davies KJ. Protein damage and degradation by oxygen radicals I. General aspects. J Biol Chem. 1987;262(20):9895–9901.
   PubMed Web of Science ®Google Scholar
• Heinecke JW, Li W, Daehnke HL3rd, Goldstein JA. Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J Biol Chem. 1993;268(6):4069–4077.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Brennan ML, Hazen SL. Serum myeloperoxidase and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2006;48(1):59–68.
   Google Scholar
• Himmelfarb J, McMenamin ME, Loseto G, Heinecke JW. Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patients. Free Radic Biol Med. 2001;31(10):1163–1169.
   PubMed Web of Science ®Google Scholar
• Heinecke JW, Li W, Francis GA, Goldstein JA. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J Clin Invest. 1993;91(6):2866–2872.
   PubMed Web of Science ®Google Scholar
• Bonomini M, Pavone B, Sirolli V, Proteomics characterization of protein adsorption onto hemodialysis membranes. J Proteome Res. 2006;5(10):2666–2674.
   Web of Science ®Google Scholar
• Mera K, Anraku M, Kitamura K, Nakajou K, Maruyama T, Otagiri M. The structure and function of oxidized albumin in hemodialysis patients: Its role in elevated oxidative stress via neutrophil burst. Biochem Biophys Res Commun. 2005;334(4): 1322–1328.
   Google Scholar
• Soejima A, Matsuzawa N, Hayashi T, Alteration of redox state of human serum albumin before and after hemodialysis. Blood Purif. 2004;22(6):525–529. Epub, December 3, 2004.
   Google Scholar
• Terawaki H, Matsuyama Y, Era S, Elevated oxidative stress measured as albumin redox state in continuous ambulatory peritoneal dialysis patients correlates with small uraemic solutes. Nephrol Dial Transplant. 2007;22(3):968.
   Google Scholar
• Robins AJ, Milewczyk BK, Booth EM, Mallick NP. Plasma amino acid abnormalities in chronic renal failure. Clin Chim Acta. 1972;42(1):215–217.
   Google Scholar
• Wilcken DE, Gupta VJ, Reddy SG. Accumulation of sulphur-containing amino acids including cysteine-homocysteine in patients on maintenance hemodialysis. Clin Sci (Lond). 1980;58(5):427–430.
   Google Scholar
• Halliwell B. Vitamin C: Antioxidant or pro-oxidant in vivo? Free Radic Res. 1996;25(5):439–454.
   PubMed Web of Science ®Google Scholar
• Lee SH, Oe T, Blair IA. Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science. 2001;292(5524):2083–2086.
   PubMed Web of Science ®Google Scholar
• Boaz M, Smetana S, Weinstein T, Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial. Lancet. 2000;356(9237):1213–1218.
   PubMed Web of Science ®Google Scholar
• Sato M, Morita H, Ema H, Yamaguchi S, Amano I. Effect of different dialyzer membranes on cutaneous microcirculation during hemodialysis. Clin Nephrol. 2006;66(6):426–432.
   Google Scholar